Novel motif:14: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:33, 9 September 2013
name: | motif14_TCNACG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0071460 | cellular response to cell-matrix adhesion | 4.627279e-21 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 5.061214e-17 |
GO:0040040 | thermosensory behavior | 5.819298e-17 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 3.195229e-13 |
GO:0051549 | positive regulation of keratinocyte migration | 7.499427e-13 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 1.556750e-12 |
GO:0043206 | fibril organization | 5.001420e-12 |
GO:0019087 | transformation of host cell by virus | 1.362202e-11 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 1.466355e-11 |
GO:0030277 | maintenance of gastrointestinal epithelium | 2.505679e-10 |
GO:0070327 | thyroid hormone transport | 5.569451e-10 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 7.832045e-10 |
GO:0033690 | positive regulation of osteoblast proliferation | 8.005544e-10 |
GO:0046687 | response to chromate | 8.135622e-10 |
GO:0033986 | response to methanol | 8.135622e-10 |
GO:0006349 | regulation of gene expression by genetic imprinting | 9.645900e-10 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 1.074909e-9 |
GO:0050746 | regulation of lipoprotein metabolic process | 1.192170e-9 |
GO:0034470 | ncRNA processing | 1.464294e-9 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 1.533553e-9 |
GO:0045338 | farnesyl diphosphate metabolic process | 2.540437e-9 |
GO:0044240 | multicellular organismal lipid catabolic process | 4.320833e-9 |
GO:0015696 | ammonium transport | 4.897694e-9 |
GO:0034378 | chylomicron assembly | 6.495788e-9 |
GO:0071514 | genetic imprinting | 6.774327e-9 |
GO:0034633 | retinol transport | 8.397962e-9 |
GO:0016090 | prenol metabolic process | 1.786811e-8 |
GO:0035094 | response to nicotine | 1.885175e-8 |
GO:0031017 | exocrine pancreas development | 2.629488e-8 |
GO:0034014 | response to triglyceride | 3.137020e-8 |
GO:0010669 | epithelial structure maintenance | 4.337875e-8 |
GO:0034442 | regulation of lipoprotein oxidation | 4.607172e-8 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 4.937484e-8 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 5.742674e-8 |
GO:2000273 | positive regulation of receptor activity | 1.464928e-7 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 3.597934e-7 |
GO:0002536 | respiratory burst involved in inflammatory response | 3.780538e-7 |
GO:0031915 | positive regulation of synaptic plasticity | 4.939851e-7 |
GO:0035966 | response to topologically incorrect protein | 5.411958e-7 |
GO:0006006 | glucose metabolic process | 6.153725e-7 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 7.229317e-7 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 7.229317e-7 |
GO:0071322 | cellular response to carbohydrate stimulus | 7.591725e-7 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 7.658307e-7 |
GO:0007208 | activation of phospholipase C activity by serotonin receptor signaling pathway | 7.658307e-7 |
GO:0008033 | tRNA processing | 7.794532e-7 |
GO:0006821 | chloride transport | 9.114640e-7 |
GO:0071333 | cellular response to glucose stimulus | 1.089842e-6 |
GO:0042396 | phosphagen biosynthetic process | 1.497876e-6 |
GO:0042373 | vitamin K metabolic process | 1.506509e-6 |
GO:0042254 | ribosome biogenesis | 2.087829e-6 |
GO:0042104 | positive regulation of activated T cell proliferation | 2.252503e-6 |
GO:0034502 | protein localization to chromosome | 2.253720e-6 |
GO:0055094 | response to lipoprotein stimulus | 2.364451e-6 |
GO:0010835 | regulation of protein ADP-ribosylation | 3.050540e-6 |
GO:0006548 | histidine catabolic process | 3.524975e-6 |
GO:0034371 | chylomicron remodeling | 3.967917e-6 |
GO:0030157 | pancreatic juice secretion | 4.518591e-6 |
GO:0002227 | innate immune response in mucosa | 4.616043e-6 |
GO:0050652 | dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 4.782492e-6 |
GO:0055090 | acylglycerol homeostasis | 4.782492e-6 |
GO:0008078 | mesodermal cell migration | 4.848357e-6 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 5.067281e-6 |
GO:0019318 | hexose metabolic process | 5.811849e-6 |
GO:0021592 | fourth ventricle development | 6.100612e-6 |
GO:0044243 | multicellular organismal catabolic process | 6.106375e-6 |
GO:0070875 | positive regulation of glycogen metabolic process | 6.148114e-6 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 6.999834e-6 |
GO:0044319 | wound healing, spreading of cells | 7.615837e-6 |
GO:0006986 | response to unfolded protein | 7.630245e-6 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 1.128943e-5 |
GO:0042069 | regulation of catecholamine metabolic process | 1.149312e-5 |
GO:0034637 | cellular carbohydrate biosynthetic process | 1.364449e-5 |
GO:0001678 | cellular glucose homeostasis | 1.401598e-5 |
GO:0019048 | virus-host interaction | 1.476380e-5 |
GO:0035025 | positive regulation of Rho protein signal transduction | 1.553277e-5 |
GO:0051764 | actin crosslink formation | 1.620548e-5 |
GO:0007158 | neuron cell-cell adhesion | 1.735477e-5 |
GO:2000304 | positive regulation of ceramide biosynthetic process | 1.780820e-5 |
GO:0046314 | phosphocreatine biosynthetic process | 1.780820e-5 |
GO:0008299 | isoprenoid biosynthetic process | 1.865376e-5 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.993601e-5 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 2.003537e-5 |
GO:0034660 | ncRNA metabolic process | 2.008422e-5 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 2.078663e-5 |
GO:0021796 | cerebral cortex regionalization | 2.214217e-5 |
GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis | 2.214217e-5 |
GO:0070198 | protein localization to chromosome, telomeric region | 2.266657e-5 |
GO:0046364 | monosaccharide biosynthetic process | 2.281294e-5 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 2.310819e-5 |
GO:0019319 | hexose biosynthetic process | 2.445596e-5 |
GO:0002041 | intussusceptive angiogenesis | 2.525509e-5 |
GO:0030823 | regulation of cGMP metabolic process | 2.808748e-5 |
GO:0060033 | anatomical structure regression | 2.815440e-5 |
GO:0034227 | tRNA thio-modification | 3.402041e-5 |
GO:0002098 | tRNA wobble uridine modification | 3.402041e-5 |
GO:0010509 | polyamine homeostasis | 3.548242e-5 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 3.671986e-5 |
GO:0035470 | positive regulation of vascular wound healing | 3.743607e-5 |
GO:0006600 | creatine metabolic process | 3.776926e-5 |
GO:0006422 | aspartyl-tRNA aminoacylation | 3.784186e-5 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 3.809509e-5 |
GO:0042574 | retinal metabolic process | 4.222758e-5 |
GO:0010288 | response to lead ion | 4.329087e-5 |
GO:0006695 | cholesterol biosynthetic process | 4.675488e-5 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 4.771158e-5 |
GO:0060216 | definitive hemopoiesis | 4.871217e-5 |
GO:0007127 | meiosis I | 4.897300e-5 |
GO:0003181 | atrioventricular valve morphogenesis | 5.131637e-5 |
GO:0031668 | cellular response to extracellular stimulus | 5.564342e-5 |
GO:2000303 | regulation of ceramide biosynthetic process | 5.703639e-5 |
GO:0042662 | negative regulation of mesodermal cell fate specification | 5.810318e-5 |
GO:0051324 | prophase | 6.198981e-5 |
GO:0006547 | histidine metabolic process | 6.242278e-5 |
GO:0035814 | negative regulation of renal sodium excretion | 6.436105e-5 |
GO:0042053 | regulation of dopamine metabolic process | 6.920666e-5 |
GO:0006094 | gluconeogenesis | 7.573671e-5 |
GO:0044258 | intestinal lipid catabolic process | 7.832671e-5 |
GO:0018350 | protein esterification | 7.832671e-5 |
GO:0006096 | glycolysis | 8.679818e-5 |
GO:0042744 | hydrogen peroxide catabolic process | 8.831903e-5 |
GO:0006364 | rRNA processing | 9.173001e-5 |
GO:0032206 | positive regulation of telomere maintenance | 9.237495e-5 |
GO:0014739 | positive regulation of muscle hyperplasia | 1.013092e-4 |
GO:0061302 | smooth muscle cell-matrix adhesion | 1.101413e-4 |
GO:0060236 | regulation of mitotic spindle organization | 1.137599e-4 |
GO:0032526 | response to retinoic acid | 1.156083e-4 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 1.206075e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 1.206075e-4 |
GO:0021918 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment | 1.229878e-4 |
GO:0071280 | cellular response to copper ion | 1.229878e-4 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 1.229878e-4 |
GO:0021905 | forebrain-midbrain boundary formation | 1.229878e-4 |
GO:0003322 | pancreatic A cell development | 1.229878e-4 |
GO:0035356 | cellular triglyceride homeostasis | 1.259140e-4 |
GO:0033189 | response to vitamin A | 1.296516e-4 |
GO:0006102 | isocitrate metabolic process | 1.342196e-4 |
GO:0023019 | signal transduction involved in regulation of gene expression | 1.384712e-4 |
GO:0042074 | cell migration involved in gastrulation | 1.416198e-4 |
GO:0035272 | exocrine system development | 1.553273e-4 |
GO:0061384 | heart trabecular morphogenesis | 1.694767e-4 |
GO:0035909 | aorta morphogenesis | 1.796058e-4 |
GO:0065002 | intracellular protein transmembrane transport | 1.805592e-4 |
GO:0007131 | reciprocal meiotic recombination | 1.873528e-4 |
GO:0031860 | telomeric 3' overhang formation | 1.900418e-4 |
GO:0016078 | tRNA catabolic process | 1.900418e-4 |
GO:0001682 | tRNA 5'-leader removal | 1.900418e-4 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.948256e-4 |
GO:0050779 | RNA destabilization | 2.013391e-4 |
GO:0061072 | iris morphogenesis | 2.032162e-4 |
GO:0060465 | pharynx development | 2.092711e-4 |
GO:0016072 | rRNA metabolic process | 2.096205e-4 |
GO:0032210 | regulation of telomere maintenance via telomerase | 2.115080e-4 |
GO:0000712 | resolution of meiotic recombination intermediates | 2.187929e-4 |
GO:0006386 | termination of RNA polymerase III transcription | 2.196525e-4 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 2.196525e-4 |
GO:0048708 | astrocyte differentiation | 2.268527e-4 |
GO:0050821 | protein stabilization | 2.330591e-4 |
GO:0045907 | positive regulation of vasoconstriction | 2.373077e-4 |
GO:0005997 | xylulose metabolic process | 2.466659e-4 |
GO:0019430 | removal of superoxide radicals | 2.495342e-4 |
GO:0021678 | third ventricle development | 2.540473e-4 |
GO:0051023 | regulation of immunoglobulin secretion | 2.567993e-4 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 2.571066e-4 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 2.571066e-4 |
GO:0046006 | regulation of activated T cell proliferation | 2.649163e-4 |
GO:0031297 | replication fork processing | 2.653748e-4 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 2.713222e-4 |
GO:0032802 | low-density lipoprotein particle receptor catabolic process | 2.754498e-4 |
GO:0022600 | digestive system process | 2.824091e-4 |
GO:0021591 | ventricular system development | 2.868526e-4 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 3.117778e-4 |
GO:0046886 | positive regulation of hormone biosynthetic process | 3.281624e-4 |
GO:0030225 | macrophage differentiation | 3.529871e-4 |
GO:0030825 | positive regulation of cGMP metabolic process | 3.623071e-4 |
GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 3.623071e-4 |
GO:0071168 | protein localization to chromatin | 3.836691e-4 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 3.855957e-4 |
GO:0032425 | positive regulation of mismatch repair | 3.971779e-4 |
GO:0001578 | microtubule bundle formation | 4.048459e-4 |
GO:0060347 | heart trabecula formation | 4.165099e-4 |
GO:0021983 | pituitary gland development | 4.176666e-4 |
GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 4.187887e-4 |
GO:0071673 | positive regulation of smooth muscle cell chemotaxis | 4.395280e-4 |
GO:0051452 | intracellular pH reduction | 4.574476e-4 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 4.637080e-4 |
GO:0002693 | positive regulation of cellular extravasation | 4.684200e-4 |
GO:0010898 | positive regulation of triglyceride catabolic process | 4.853203e-4 |
GO:0021986 | habenula development | 4.903895e-4 |
GO:0051932 | synaptic transmission, GABAergic | 4.949410e-4 |
GO:0034241 | positive regulation of macrophage fusion | 4.949410e-4 |
GO:0000380 | alternative nuclear mRNA splicing, via spliceosome | 5.052293e-4 |
GO:0070873 | regulation of glycogen metabolic process | 5.103590e-4 |
GO:0045940 | positive regulation of steroid metabolic process | 5.134075e-4 |
GO:0034389 | lipid particle organization | 5.256007e-4 |
GO:0030070 | insulin processing | 5.256007e-4 |
GO:0035813 | regulation of renal sodium excretion | 5.382401e-4 |
GO:0019049 | evasion of host defenses by virus | 5.719773e-4 |
GO:0051024 | positive regulation of immunoglobulin secretion | 5.739230e-4 |
GO:0071105 | response to interleukin-11 | 5.939925e-4 |
GO:0090030 | regulation of steroid hormone biosynthetic process | 6.044505e-4 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 6.084484e-4 |
GO:0046165 | alcohol biosynthetic process | 6.127019e-4 |
GO:0044062 | regulation of excretion | 6.351199e-4 |
GO:0006383 | transcription from RNA polymerase III promoter | 6.453370e-4 |
GO:0060807 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification | 6.457101e-4 |
GO:0003142 | cardiogenic plate morphogenesis | 6.457101e-4 |
GO:0070328 | triglyceride homeostasis | 6.620408e-4 |
GO:0040029 | regulation of gene expression, epigenetic | 6.621708e-4 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 6.625315e-4 |
GO:0070301 | cellular response to hydrogen peroxide | 6.715151e-4 |
GO:0090303 | positive regulation of wound healing | 6.915248e-4 |
GO:0035967 | cellular response to topologically incorrect protein | 7.265376e-4 |
GO:0043985 | histone H4-R3 methylation | 7.363250e-4 |
GO:0014738 | regulation of muscle hyperplasia | 7.363250e-4 |
GO:0042135 | neurotransmitter catabolic process | 7.367028e-4 |
GO:0021978 | telencephalon regionalization | 7.403521e-4 |
GO:0032202 | telomere assembly | 7.420311e-4 |
GO:0072337 | modified amino acid transport | 7.605423e-4 |
GO:0060413 | atrial septum morphogenesis | 7.611409e-4 |
GO:0030826 | regulation of cGMP biosynthetic process | 7.880622e-4 |
GO:0035845 | photoreceptor cell outer segment organization | 8.797407e-4 |
GO:0035499 | carnosine biosynthetic process | 8.797407e-4 |
GO:0051303 | establishment of chromosome localization | 8.995418e-4 |
GO:0033566 | gamma-tubulin complex localization | 9.287395e-4 |
GO:0006260 | DNA replication | 9.329503e-4 |
GO:0030198 | extracellular matrix organization | 9.401490e-4 |
GO:0045132 | meiotic chromosome segregation | 9.443692e-4 |
GO:0006447 | regulation of translational initiation by iron | 9.765478e-4 |
GO:0016233 | telomere capping | 9.765478e-4 |
GO:0045851 | pH reduction | 1.007755e-3 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 1.013438e-3 |
GO:0006412 | translation | 1.020650e-3 |
GO:0006007 | glucose catabolic process | 1.031092e-3 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 1.078140e-3 |
GO:0045994 | positive regulation of translational initiation by iron | 1.081469e-3 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 1.081469e-3 |
GO:0002037 | negative regulation of L-glutamate transport | 1.081469e-3 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 1.082587e-3 |
GO:0044236 | multicellular organismal metabolic process | 1.094819e-3 |
GO:0000022 | mitotic spindle elongation | 1.141691e-3 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 1.142616e-3 |
GO:0007052 | mitotic spindle organization | 1.150127e-3 |
GO:0006081 | cellular aldehyde metabolic process | 1.169159e-3 |
GO:0034629 | cellular protein complex localization | 1.188629e-3 |
GO:0003283 | atrial septum development | 1.193429e-3 |
GO:0007223 | Wnt receptor signaling pathway, calcium modulating pathway | 1.242584e-3 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 1.245639e-3 |
GO:0010624 | regulation of Schwann cell proliferation | 1.257396e-3 |
GO:0010715 | regulation of extracellular matrix disassembly | 1.259340e-3 |
GO:0015936 | coenzyme A metabolic process | 1.261022e-3 |
GO:0042552 | myelination | 1.303944e-3 |
GO:0007589 | body fluid secretion | 1.313548e-3 |
GO:0006458 | 'de novo' protein folding | 1.361794e-3 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 1.367080e-3 |
GO:0051310 | metaphase plate congression | 1.400333e-3 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.403647e-3 |
GO:0031848 | protection from non-homologous end joining at telomere | 1.412700e-3 |
GO:0035313 | wound healing, spreading of epidermal cells | 1.423852e-3 |
GO:0030221 | basophil differentiation | 1.446688e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 1.446729e-3 |
GO:0003278 | apoptosis involved in heart morphogenesis | 1.461810e-3 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 1.522939e-3 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 1.522939e-3 |
GO:0032682 | negative regulation of chemokine production | 1.538879e-3 |
GO:0031284 | positive regulation of guanylate cyclase activity | 1.538879e-3 |
GO:0060712 | spongiotrophoblast layer development | 1.557151e-3 |
GO:0010002 | cardioblast differentiation | 1.640800e-3 |
GO:0007586 | digestion | 1.643486e-3 |
GO:0005996 | monosaccharide metabolic process | 1.690000e-3 |
GO:0006768 | biotin metabolic process | 1.694621e-3 |
GO:0048205 | COPI coating of Golgi vesicle | 1.701617e-3 |
GO:0046730 | induction of host immune response by virus | 1.718235e-3 |
GO:0043587 | tongue morphogenesis | 1.768274e-3 |
GO:0005999 | xylulose biosynthetic process | 1.798670e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.858990e-3 |
GO:0002678 | positive regulation of chronic inflammatory response | 1.858990e-3 |
GO:0006228 | UTP biosynthetic process | 1.878531e-3 |
GO:0045040 | protein import into mitochondrial outer membrane | 1.878531e-3 |
GO:0006183 | GTP biosynthetic process | 1.878531e-3 |
GO:0006165 | nucleoside diphosphate phosphorylation | 1.878531e-3 |
GO:0006457 | protein folding | 1.904413e-3 |
GO:0033169 | histone H3-K9 demethylation | 1.934128e-3 |
GO:0044003 | modification by symbiont of host morphology or physiology | 1.954660e-3 |
GO:0034969 | histone arginine methylation | 1.958681e-3 |
GO:0051302 | regulation of cell division | 1.986111e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.986756e-3 |
GO:0032235 | negative regulation of calcium ion transport via store-operated calcium channel activity | 2.042197e-3 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 2.044944e-3 |
GO:0010896 | regulation of triglyceride catabolic process | 2.046545e-3 |
GO:0006391 | transcription initiation from mitochondrial promoter | 2.052026e-3 |
GO:0070212 | protein poly-ADP-ribosylation | 2.071530e-3 |
GO:0005979 | regulation of glycogen biosynthetic process | 2.078290e-3 |
GO:0009589 | detection of UV | 2.103489e-3 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 2.103489e-3 |
GO:0010477 | response to sulfur dioxide | 2.103489e-3 |
GO:0002457 | T cell antigen processing and presentation | 2.103489e-3 |
GO:0000088 | mitotic prophase | 2.103489e-3 |
GO:0032233 | positive regulation of actin filament bundle assembly | 2.134068e-3 |
GO:0061014 | positive regulation of mRNA catabolic process | 2.155150e-3 |
GO:0000303 | response to superoxide | 2.170662e-3 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 2.173748e-3 |
GO:0071529 | cementum mineralization | 2.189564e-3 |
GO:0046889 | positive regulation of lipid biosynthetic process | 2.197059e-3 |
GO:0032224 | positive regulation of synaptic transmission, cholinergic | 2.258686e-3 |
GO:0022613 | ribonucleoprotein complex biogenesis | 2.281882e-3 |
GO:0035910 | ascending aorta morphogenesis | 2.325178e-3 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 2.325178e-3 |
GO:0060042 | retina morphogenesis in camera-type eye | 2.335157e-3 |
GO:0007128 | meiotic prophase I | 2.341379e-3 |
GO:0001985 | negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure | 2.344647e-3 |
GO:0042149 | cellular response to glucose starvation | 2.363677e-3 |
GO:0034375 | high-density lipoprotein particle remodeling | 2.367621e-3 |
GO:0051013 | microtubule severing | 2.431381e-3 |
GO:0032790 | ribosome disassembly | 2.431381e-3 |
GO:0046108 | uridine metabolic process | 2.431381e-3 |
GO:0051781 | positive regulation of cell division | 2.444531e-3 |
GO:0071218 | cellular response to misfolded protein | 2.507412e-3 |
GO:0010469 | regulation of receptor activity | 2.513291e-3 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 2.539717e-3 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 2.583052e-3 |
GO:0046549 | retinal cone cell development | 2.586516e-3 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.603638e-3 |
GO:0014912 | negative regulation of smooth muscle cell migration | 2.673012e-3 |
GO:0021517 | ventral spinal cord development | 2.692235e-3 |
GO:0010893 | positive regulation of steroid biosynthetic process | 2.704180e-3 |
GO:0035195 | gene silencing by miRNA | 2.793374e-3 |
GO:0021670 | lateral ventricle development | 2.795192e-3 |
GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production | 2.802977e-3 |
GO:0072086 | specification of loop of Henle identity | 2.802977e-3 |
GO:0006651 | diacylglycerol biosynthetic process | 2.832659e-3 |
GO:0015698 | inorganic anion transport | 2.910801e-3 |
GO:0019883 | antigen processing and presentation of endogenous antigen | 2.914690e-3 |
GO:0031053 | primary miRNA processing | 2.967243e-3 |
GO:0035020 | regulation of Rac protein signal transduction | 2.982568e-3 |
GO:0070208 | protein heterotrimerization | 3.050475e-3 |
GO:0043243 | positive regulation of protein complex disassembly | 3.078296e-3 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 3.094026e-3 |
GO:0030836 | positive regulation of actin filament depolymerization | 3.094026e-3 |
GO:0008635 | activation of caspase activity by cytochrome c | 3.094026e-3 |
GO:0000089 | mitotic metaphase | 3.094026e-3 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 3.115631e-3 |
GO:0031647 | regulation of protein stability | 3.126225e-3 |
GO:0010907 | positive regulation of glucose metabolic process | 3.161998e-3 |
GO:2000778 | positive regulation of interleukin-6 secretion | 3.230646e-3 |
GO:0048013 | ephrin receptor signaling pathway | 3.279581e-3 |
GO:0060976 | coronary vasculature development | 3.318948e-3 |
GO:0015761 | mannose transport | 3.325874e-3 |
GO:0031081 | nuclear pore distribution | 3.325874e-3 |
GO:0009451 | RNA modification | 3.409789e-3 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 3.447822e-3 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 3.482244e-3 |
GO:0035732 | nitric oxide storage | 3.482244e-3 |
GO:0035726 | common myeloid progenitor cell proliferation | 3.482244e-3 |
GO:0031627 | telomeric loop formation | 3.482244e-3 |
GO:0006261 | DNA-dependent DNA replication | 3.515729e-3 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 3.520225e-3 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 3.520225e-3 |
GO:0030431 | sleep | 3.534420e-3 |
GO:0001522 | pseudouridine synthesis | 3.585404e-3 |
GO:0019059 | initiation of viral infection | 3.683795e-3 |
GO:0060999 | positive regulation of dendritic spine development | 3.701902e-3 |
GO:0045104 | intermediate filament cytoskeleton organization | 3.718932e-3 |
GO:0034614 | cellular response to reactive oxygen species | 3.827154e-3 |
GO:0072593 | reactive oxygen species metabolic process | 3.833137e-3 |
GO:0052066 | entry of symbiont into host cell by promotion of host phagocytosis | 3.856551e-3 |
GO:0035635 | entry of bacterium into host cell | 3.856551e-3 |
GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 3.856551e-3 |
GO:0003170 | heart valve development | 3.870726e-3 |
GO:0060290 | transdifferentiation | 3.891159e-3 |
GO:0008366 | axon ensheathment | 3.892675e-3 |
GO:0042593 | glucose homeostasis | 3.938853e-3 |
GO:0032352 | positive regulation of hormone metabolic process | 3.956006e-3 |
GO:0051321 | meiotic cell cycle | 3.991238e-3 |
GO:0060563 | neuroepithelial cell differentiation | 4.055174e-3 |
GO:0048194 | Golgi vesicle budding | 4.090092e-3 |
GO:0007088 | regulation of mitosis | 4.118031e-3 |
GO:0003206 | cardiac chamber morphogenesis | 4.130227e-3 |
GO:0006772 | thiamine metabolic process | 4.169036e-3 |
GO:0044275 | cellular carbohydrate catabolic process | 4.193619e-3 |
GO:2000188 | regulation of cholesterol homeostasis | 4.225387e-3 |
GO:0046939 | nucleotide phosphorylation | 4.237362e-3 |
GO:0016126 | sterol biosynthetic process | 4.285255e-3 |
GO:0040009 | regulation of growth rate | 4.394885e-3 |
GO:0007495 | visceral mesoderm-endoderm interaction involved in midgut development | 4.394885e-3 |
GO:0035022 | positive regulation of Rac protein signal transduction | 4.417757e-3 |
GO:0033688 | regulation of osteoblast proliferation | 4.458641e-3 |
GO:0045820 | negative regulation of glycolysis | 4.481569e-3 |
GO:0003289 | atrial septum primum morphogenesis | 4.481569e-3 |
GO:0030497 | fatty acid elongation | 4.495844e-3 |
GO:0007183 | SMAD protein complex assembly | 4.504547e-3 |
GO:2000691 | negative regulation of cardiac muscle cell myoblast differentiation | 4.511605e-3 |
GO:0042109 | lymphotoxin A biosynthetic process | 4.511605e-3 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 4.529290e-3 |
GO:0021536 | diencephalon development | 4.610166e-3 |
GO:0014910 | regulation of smooth muscle cell migration | 4.690206e-3 |
GO:0042572 | retinol metabolic process | 4.736930e-3 |
GO:0022011 | myelination in peripheral nervous system | 4.736930e-3 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 4.764650e-3 |
GO:0019367 | fatty acid elongation, saturated fatty acid | 4.780083e-3 |
GO:0006564 | L-serine biosynthetic process | 4.815961e-3 |
GO:0051496 | positive regulation of stress fiber assembly | 4.917515e-3 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 4.954932e-3 |
GO:0001754 | eye photoreceptor cell differentiation | 4.955735e-3 |
GO:2000002 | negative regulation of DNA damage checkpoint | 5.089437e-3 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 5.089437e-3 |
GO:0021551 | central nervous system morphogenesis | 5.089437e-3 |
GO:0021588 | cerebellum formation | 5.089437e-3 |
GO:0060022 | hard palate development | 5.137951e-3 |
GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine | 5.137951e-3 |
GO:0050686 | negative regulation of mRNA processing | 5.142363e-3 |
GO:0010936 | negative regulation of macrophage cytokine production | 5.142363e-3 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 5.142363e-3 |
GO:0006720 | isoprenoid metabolic process | 5.187787e-3 |
GO:0032212 | positive regulation of telomere maintenance via telomerase | 5.266187e-3 |
GO:0051798 | positive regulation of hair follicle development | 5.267165e-3 |
GO:0032075 | positive regulation of nuclease activity | 5.297798e-3 |
GO:0014707 | branchiomeric skeletal muscle development | 5.299846e-3 |
GO:0032964 | collagen biosynthetic process | 5.358168e-3 |
GO:0043255 | regulation of carbohydrate biosynthetic process | 5.381932e-3 |
GO:0006270 | DNA-dependent DNA replication initiation | 5.411155e-3 |
GO:0060904 | regulation of protein folding in endoplasmic reticulum | 5.434122e-3 |
GO:0021589 | cerebellum structural organization | 5.434122e-3 |
GO:0000492 | box C/D snoRNP assembly | 5.537304e-3 |
GO:0000305 | response to oxygen radical | 5.543263e-3 |
GO:2000380 | regulation of mesoderm development | 5.549702e-3 |
GO:0007023 | post-chaperonin tubulin folding pathway | 5.693255e-3 |
GO:0046548 | retinal rod cell development | 5.728599e-3 |
GO:0000072 | M phase specific microtubule process | 5.814636e-3 |
GO:0060575 | intestinal epithelial cell differentiation | 6.046312e-3 |
GO:0033627 | cell adhesion mediated by integrin | 6.046312e-3 |
GO:0016082 | synaptic vesicle priming | 6.076033e-3 |
GO:0051156 | glucose 6-phosphate metabolic process | 6.109454e-3 |
GO:0032211 | negative regulation of telomere maintenance via telomerase | 6.109454e-3 |
GO:0006399 | tRNA metabolic process | 6.116803e-3 |
GO:0035634 | response to stilbenoid | 6.180629e-3 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 6.392441e-3 |
GO:0006396 | RNA processing | 6.397872e-3 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 6.407986e-3 |
GO:0021854 | hypothalamus development | 6.465049e-3 |
GO:0003179 | heart valve morphogenesis | 6.595315e-3 |
GO:0060411 | cardiac septum morphogenesis | 6.688395e-3 |
GO:0071474 | cellular hyperosmotic response | 6.714993e-3 |
GO:0048593 | camera-type eye morphogenesis | 6.736257e-3 |
GO:0032793 | positive regulation of CREB transcription factor activity | 6.799412e-3 |
GO:0072268 | pattern specification involved in metanephros development | 6.901198e-3 |
GO:0018206 | peptidyl-methionine modification | 6.901198e-3 |
GO:0022415 | viral reproductive process | 6.958198e-3 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 6.968383e-3 |
GO:0042450 | arginine biosynthetic process via ornithine | 6.968383e-3 |
GO:0021771 | lateral geniculate nucleus development | 6.968383e-3 |
GO:0042661 | regulation of mesodermal cell fate specification | 6.979384e-3 |
GO:0033235 | positive regulation of protein sumoylation | 6.997602e-3 |
GO:0045074 | regulation of interleukin-10 biosynthetic process | 7.068632e-3 |
GO:0006241 | CTP biosynthetic process | 7.074373e-3 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 7.113389e-3 |
GO:0007217 | tachykinin receptor signaling pathway | 7.120166e-3 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 7.155416e-3 |
GO:0007006 | mitochondrial membrane organization | 7.188943e-3 |
GO:0019478 | D-amino acid catabolic process | 7.193329e-3 |
GO:0009107 | lipoate biosynthetic process | 7.193329e-3 |
GO:0071277 | cellular response to calcium ion | 7.242252e-3 |
GO:0002663 | positive regulation of B cell tolerance induction | 7.248479e-3 |
GO:0033484 | nitric oxide homeostasis | 7.300835e-3 |
GO:0046339 | diacylglycerol metabolic process | 7.366378e-3 |
GO:0002089 | lens morphogenesis in camera-type eye | 7.394038e-3 |
GO:0051323 | metaphase | 7.470522e-3 |
GO:0019320 | hexose catabolic process | 7.498423e-3 |
GO:0021778 | oligodendrocyte cell fate specification | 7.500689e-3 |
GO:0001579 | medium-chain fatty acid transport | 7.726596e-3 |
GO:2000824 | negative regulation of androgen receptor activity | 7.726596e-3 |
GO:0060219 | camera-type eye photoreceptor cell differentiation | 7.736425e-3 |
GO:0034508 | centromere complex assembly | 7.762075e-3 |
GO:0006984 | ER-nucleus signaling pathway | 7.788210e-3 |
GO:0071875 | adrenergic receptor signaling pathway | 7.818664e-3 |
GO:0003183 | mitral valve morphogenesis | 7.818664e-3 |
GO:0051956 | negative regulation of amino acid transport | 7.882097e-3 |
GO:0010676 | positive regulation of cellular carbohydrate metabolic process | 7.891767e-3 |
GO:0007126 | meiosis | 7.903618e-3 |
GO:0009584 | detection of visible light | 7.906461e-3 |
GO:0032071 | regulation of endodeoxyribonuclease activity | 8.079268e-3 |
GO:0019682 | glyceraldehyde-3-phosphate metabolic process | 8.079268e-3 |
GO:0042942 | D-serine transport | 8.079268e-3 |
GO:0002508 | central tolerance induction | 8.079268e-3 |
GO:0002897 | positive regulation of central B cell tolerance induction | 8.079268e-3 |
GO:0016598 | protein arginylation | 8.079268e-3 |
GO:0016032 | viral reproduction | 8.079692e-3 |
GO:0035928 | rRNA import into mitochondrion | 8.128059e-3 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 8.170868e-3 |
GO:0042226 | interleukin-6 biosynthetic process | 8.193328e-3 |
GO:0072668 | tubulin complex biogenesis | 8.243539e-3 |
GO:0046833 | positive regulation of RNA export from nucleus | 8.347053e-3 |
GO:0051882 | mitochondrial depolarization | 8.347053e-3 |
GO:0042270 | protection from natural killer cell mediated cytotoxicity | 8.347053e-3 |
GO:0002882 | positive regulation of chronic inflammatory response to non-antigenic stimulus | 8.347053e-3 |
GO:0016142 | O-glycoside catabolic process | 8.347053e-3 |
GO:0031120 | snRNA pseudouridine synthesis | 8.347053e-3 |
GO:0042424 | catecholamine catabolic process | 8.394971e-3 |
GO:0072081 | specification of nephron tubule identity | 8.508288e-3 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 8.513784e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0042254 | ribosome biogenesis | 2.447309e-12 |
GO:0016072 | rRNA metabolic process | 1.144581e-11 |
GO:0048668 | collateral sprouting | 6.312683e-11 |
GO:0006364 | rRNA processing | 1.100909e-10 |
GO:0034470 | ncRNA processing | 1.657762e-10 |
GO:0071843 | cellular component biogenesis at cellular level | 1.875806e-10 |
GO:0015986 | ATP synthesis coupled proton transport | 3.180184e-10 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 3.595743e-10 |
GO:0022613 | ribonucleoprotein complex biogenesis | 5.794579e-10 |
GO:0034660 | ncRNA metabolic process | 1.674830e-9 |
GO:0006507 | GPI anchor release | 2.117783e-9 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.624407e-8 |
GO:0006396 | RNA processing | 1.628775e-8 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 1.723341e-8 |
GO:0035967 | cellular response to topologically incorrect protein | 5.179993e-8 |
GO:0034442 | regulation of lipoprotein oxidation | 5.393159e-8 |
GO:0007052 | mitotic spindle organization | 7.817442e-8 |
GO:0043623 | cellular protein complex assembly | 9.461730e-8 |
GO:0007632 | visual behavior | 1.006028e-7 |
GO:0006308 | DNA catabolic process | 1.118401e-7 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.127954e-7 |
GO:0090304 | nucleic acid metabolic process | 1.255177e-7 |
GO:0055090 | acylglycerol homeostasis | 1.699931e-7 |
GO:0006986 | response to unfolded protein | 1.878132e-7 |
GO:0008542 | visual learning | 1.931304e-7 |
GO:0090307 | spindle assembly involved in mitosis | 2.301198e-7 |
GO:0007051 | spindle organization | 2.460395e-7 |
GO:0006306 | DNA methylation | 2.768244e-7 |
GO:0045040 | protein import into mitochondrial outer membrane | 2.808565e-7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3.330278e-7 |
GO:0051258 | protein polymerization | 4.201062e-7 |
GO:0048669 | collateral sprouting in absence of injury | 4.737352e-7 |
GO:0007618 | mating | 5.100265e-7 |
GO:0010312 | detoxification of zinc ion | 5.201544e-7 |
GO:0010467 | gene expression | 6.556735e-7 |
GO:0006982 | response to lipid hydroperoxide | 7.777934e-7 |
GO:0030202 | heparin metabolic process | 8.512272e-7 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 1.026524e-6 |
GO:0010936 | negative regulation of macrophage cytokine production | 1.145346e-6 |
GO:0002092 | positive regulation of receptor internalization | 1.145346e-6 |
GO:0060051 | negative regulation of protein glycosylation | 1.237513e-6 |
GO:0016074 | snoRNA metabolic process | 1.380902e-6 |
GO:0006807 | nitrogen compound metabolic process | 1.472439e-6 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 1.545396e-6 |
GO:0055070 | copper ion homeostasis | 1.769050e-6 |
GO:0044237 | cellular metabolic process | 1.850603e-6 |
GO:0050689 | negative regulation of defense response to virus by host | 1.938237e-6 |
GO:0010898 | positive regulation of triglyceride catabolic process | 2.166318e-6 |
GO:0000085 | G2 phase of mitotic cell cycle | 2.185834e-6 |
GO:0009817 | defense response to fungus, incompatible interaction | 2.708449e-6 |
GO:0006878 | cellular copper ion homeostasis | 3.179806e-6 |
GO:0019098 | reproductive behavior | 4.242112e-6 |
GO:0061088 | regulation of sequestering of zinc ion | 4.333201e-6 |
GO:0060049 | regulation of protein glycosylation | 4.333201e-6 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 4.593215e-6 |
GO:0032465 | regulation of cytokinesis | 4.817813e-6 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 5.169046e-6 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 5.169046e-6 |
GO:0044260 | cellular macromolecule metabolic process | 5.373610e-6 |
GO:0034976 | response to endoplasmic reticulum stress | 5.383829e-6 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 5.549383e-6 |
GO:0035966 | response to topologically incorrect protein | 6.406953e-6 |
GO:0006206 | pyrimidine base metabolic process | 6.485011e-6 |
GO:0007617 | mating behavior | 6.792947e-6 |
GO:0035092 | sperm chromatin condensation | 7.739052e-6 |
GO:0006412 | translation | 1.048904e-5 |
GO:0006084 | acetyl-CoA metabolic process | 1.049304e-5 |
GO:0022007 | convergent extension involved in neural plate elongation | 1.066269e-5 |
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 1.066269e-5 |
GO:0016070 | RNA metabolic process | 1.088023e-5 |
GO:0021794 | thalamus development | 1.091038e-5 |
GO:0006984 | ER-nucleus signaling pathway | 1.219652e-5 |
GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 1.288146e-5 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 1.358469e-5 |
GO:0040029 | regulation of gene expression, epigenetic | 1.502384e-5 |
GO:0032467 | positive regulation of cytokinesis | 1.619204e-5 |
GO:0051124 | synaptic growth at neuromuscular junction | 1.636480e-5 |
GO:0051225 | spindle assembly | 1.680151e-5 |
GO:0006561 | proline biosynthetic process | 1.715364e-5 |
GO:0043932 | ossification involved in bone remodeling | 1.715364e-5 |
GO:0001829 | trophectodermal cell differentiation | 1.781061e-5 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 2.056263e-5 |
GO:0030970 | retrograde protein transport, ER to cytosol | 2.205605e-5 |
GO:0050746 | regulation of lipoprotein metabolic process | 2.398052e-5 |
GO:0007017 | microtubule-based process | 2.539824e-5 |
GO:0007183 | SMAD protein complex assembly | 2.771626e-5 |
GO:0006818 | hydrogen transport | 2.787812e-5 |
GO:0002227 | innate immune response in mucosa | 2.876986e-5 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 2.907482e-5 |
GO:0090285 | negative regulation of protein glycosylation in Golgi | 3.016540e-5 |
GO:0009451 | RNA modification | 3.116379e-5 |
GO:0060124 | positive regulation of growth hormone secretion | 3.320435e-5 |
GO:0015992 | proton transport | 3.342894e-5 |
GO:2000781 | positive regulation of double-strand break repair | 3.413709e-5 |
GO:0016140 | O-glycoside metabolic process | 3.413709e-5 |
GO:0001522 | pseudouridine synthesis | 3.466559e-5 |
GO:0019049 | evasion of host defenses by virus | 3.591806e-5 |
GO:0046958 | nonassociative learning | 3.879783e-5 |
GO:0006754 | ATP biosynthetic process | 4.039562e-5 |
GO:0019430 | removal of superoxide radicals | 4.052259e-5 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 4.142411e-5 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 4.142411e-5 |
GO:0045362 | positive regulation of interleukin-1 biosynthetic process | 4.142411e-5 |
GO:0032707 | negative regulation of interleukin-23 production | 4.142411e-5 |
GO:0016142 | O-glycoside catabolic process | 4.142411e-5 |
GO:0045617 | negative regulation of keratinocyte differentiation | 4.186116e-5 |
GO:0045357 | regulation of interferon-beta biosynthetic process | 4.991900e-5 |
GO:0002513 | tolerance induction to self antigen | 5.208642e-5 |
GO:0001824 | blastocyst development | 5.620283e-5 |
GO:0070194 | synaptonemal complex disassembly | 6.060861e-5 |
GO:0042417 | dopamine metabolic process | 6.313565e-5 |
GO:0002537 | nitric oxide production involved in inflammatory response | 6.684086e-5 |
GO:0001839 | neural plate morphogenesis | 6.883287e-5 |
GO:0006505 | GPI anchor metabolic process | 7.399108e-5 |
GO:0060390 | regulation of SMAD protein import into nucleus | 7.604265e-5 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 7.785649e-5 |
GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 7.879642e-5 |
GO:0032648 | regulation of interferon-beta production | 7.880635e-5 |
GO:0000305 | response to oxygen radical | 7.897405e-5 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 7.914431e-5 |
GO:0031396 | regulation of protein ubiquitination | 8.285646e-5 |
GO:0000738 | DNA catabolic process, exonucleolytic | 8.604905e-5 |
GO:0045844 | positive regulation of striated muscle tissue development | 9.137432e-5 |
GO:0021860 | pyramidal neuron development | 9.434160e-5 |
GO:0050765 | negative regulation of phagocytosis | 9.600613e-5 |
GO:0006465 | signal peptide processing | 9.655932e-5 |
GO:0051302 | regulation of cell division | 1.173339e-4 |
GO:0015761 | mannose transport | 1.210412e-4 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 1.239024e-4 |
GO:0006259 | DNA metabolic process | 1.261669e-4 |
GO:0006304 | DNA modification | 1.279364e-4 |
GO:0018364 | peptidyl-glutamine methylation | 1.377070e-4 |
GO:0000226 | microtubule cytoskeleton organization | 1.401276e-4 |
GO:0000103 | sulfate assimilation | 1.407862e-4 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.457544e-4 |
GO:0010561 | negative regulation of glycoprotein biosynthetic process | 1.457544e-4 |
GO:0032218 | riboflavin transport | 1.474240e-4 |
GO:0033194 | response to hydroperoxide | 1.564241e-4 |
GO:0032606 | type I interferon production | 1.578539e-4 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 1.690233e-4 |
GO:0033135 | regulation of peptidyl-serine phosphorylation | 1.702655e-4 |
GO:0015012 | heparan sulfate proteoglycan biosynthetic process | 1.726566e-4 |
GO:0007008 | outer mitochondrial membrane organization | 1.751635e-4 |
GO:0032967 | positive regulation of collagen biosynthetic process | 1.814057e-4 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 1.882757e-4 |
GO:0016322 | neuron remodeling | 1.963768e-4 |
GO:0032479 | regulation of type I interferon production | 2.002018e-4 |
GO:0018206 | peptidyl-methionine modification | 2.008349e-4 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 2.210277e-4 |
GO:0045090 | retroviral genome replication | 2.210277e-4 |
GO:0001682 | tRNA 5'-leader removal | 2.210277e-4 |
GO:0016078 | tRNA catabolic process | 2.210277e-4 |
GO:0035372 | protein localization to microtubule | 2.212832e-4 |
GO:0001555 | oocyte growth | 2.391762e-4 |
GO:0016926 | protein desumoylation | 2.404777e-4 |
GO:0006099 | tricarboxylic acid cycle | 2.488003e-4 |
GO:0008535 | respiratory chain complex IV assembly | 2.510412e-4 |
GO:0006085 | acetyl-CoA biosynthetic process | 2.510412e-4 |
GO:0032727 | positive regulation of interferon-alpha production | 2.531810e-4 |
GO:0048599 | oocyte development | 2.543975e-4 |
GO:0032259 | methylation | 2.576568e-4 |
GO:0050668 | positive regulation of homocysteine metabolic process | 2.606118e-4 |
GO:0045963 | negative regulation of dopamine metabolic process | 2.606118e-4 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 2.606118e-4 |
GO:0022900 | electron transport chain | 2.714024e-4 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 2.857758e-4 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 2.910430e-4 |
GO:0090208 | positive regulation of triglyceride metabolic process | 3.098424e-4 |
GO:0043154 | negative regulation of caspase activity | 3.102850e-4 |
GO:0034622 | cellular macromolecular complex assembly | 3.103960e-4 |
GO:0080164 | regulation of nitric oxide metabolic process | 3.117823e-4 |
GO:0051932 | synaptic transmission, GABAergic | 3.117823e-4 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 3.117823e-4 |
GO:0018158 | protein oxidation | 3.130453e-4 |
GO:0006413 | translational initiation | 3.145536e-4 |
GO:0007614 | short-term memory | 3.147486e-4 |
GO:0006560 | proline metabolic process | 3.362402e-4 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 3.365773e-4 |
GO:0001825 | blastocyst formation | 3.367148e-4 |
GO:0007528 | neuromuscular junction development | 3.373523e-4 |
GO:0009994 | oocyte differentiation | 3.394722e-4 |
GO:0046512 | sphingosine biosynthetic process | 3.396098e-4 |
GO:0030857 | negative regulation of epithelial cell differentiation | 3.548113e-4 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 3.596229e-4 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 3.633031e-4 |
GO:0060071 | Wnt receptor signaling pathway, planar cell polarity pathway | 3.642963e-4 |
GO:0001840 | neural plate development | 3.680383e-4 |
GO:0034614 | cellular response to reactive oxygen species | 3.711966e-4 |
GO:0033211 | adiponectin-mediated signaling pathway | 3.787848e-4 |
GO:0016073 | snRNA metabolic process | 3.787848e-4 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 3.839824e-4 |
GO:0060364 | frontal suture morphogenesis | 3.870083e-4 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 3.930193e-4 |
GO:0051781 | positive regulation of cell division | 3.996401e-4 |
GO:0061034 | olfactory bulb mitral cell layer development | 4.097367e-4 |
GO:0031536 | positive regulation of exit from mitosis | 4.097367e-4 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 4.275137e-4 |
GO:0045351 | type I interferon biosynthetic process | 4.705666e-4 |
GO:0033601 | positive regulation of mammary gland epithelial cell proliferation | 4.705666e-4 |
GO:0021670 | lateral ventricle development | 4.758079e-4 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 4.785461e-4 |
GO:0006383 | transcription from RNA polymerase III promoter | 5.113570e-4 |
GO:0034621 | cellular macromolecular complex subunit organization | 5.289667e-4 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 5.398961e-4 |
GO:0008306 | associative learning | 5.830952e-4 |
GO:0010896 | regulation of triglyceride catabolic process | 5.840898e-4 |
GO:0052200 | response to host defenses | 5.848878e-4 |
GO:0030262 | apoptotic nuclear change | 5.933474e-4 |
GO:0021695 | cerebellar cortex development | 5.991234e-4 |
GO:0008033 | tRNA processing | 6.123277e-4 |
GO:0048643 | positive regulation of skeletal muscle tissue development | 6.299511e-4 |
GO:0007519 | skeletal muscle tissue development | 6.300138e-4 |
GO:0060676 | ureteric bud formation | 6.443092e-4 |
GO:0021592 | fourth ventricle development | 6.622924e-4 |
GO:0035066 | positive regulation of histone acetylation | 6.696215e-4 |
GO:0048741 | skeletal muscle fiber development | 6.775732e-4 |
GO:0032853 | positive regulation of Ran GTPase activity | 6.882543e-4 |
GO:0071169 | establishment of protein localization to chromatin | 6.882543e-4 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 6.882543e-4 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 6.954192e-4 |
GO:0034394 | protein localization at cell surface | 7.044790e-4 |
GO:0043414 | macromolecule methylation | 7.097353e-4 |
GO:0006868 | glutamine transport | 7.188029e-4 |
GO:0006777 | Mo-molybdopterin cofactor biosynthetic process | 7.188029e-4 |
GO:0032922 | circadian regulation of gene expression | 7.215666e-4 |
GO:0021591 | ventricular system development | 7.271816e-4 |
GO:0045746 | negative regulation of Notch signaling pathway | 7.489043e-4 |
GO:0048627 | myoblast development | 7.685122e-4 |
GO:0021539 | subthalamus development | 7.685122e-4 |
GO:0046836 | glycolipid transport | 7.685122e-4 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 8.049426e-4 |
GO:0007517 | muscle organ development | 8.280876e-4 |
GO:0006670 | sphingosine metabolic process | 8.287622e-4 |
GO:0060056 | mammary gland involution | 8.299331e-4 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 8.309290e-4 |
GO:0006086 | acetyl-CoA biosynthetic process from pyruvate | 8.379554e-4 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 8.723359e-4 |
GO:0018200 | peptidyl-glutamic acid modification | 8.830173e-4 |
GO:0031398 | positive regulation of protein ubiquitination | 8.856918e-4 |
GO:0007612 | learning | 9.311027e-4 |
GO:0042559 | pteridine-containing compound biosynthetic process | 9.386344e-4 |
GO:0014707 | branchiomeric skeletal muscle development | 9.614300e-4 |
GO:0060538 | skeletal muscle organ development | 9.798762e-4 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 1.022991e-3 |
GO:0031058 | positive regulation of histone modification | 1.025780e-3 |
GO:0046356 | acetyl-CoA catabolic process | 1.030202e-3 |
GO:0046755 | non-lytic virus budding | 1.062861e-3 |
GO:0006391 | transcription initiation from mitochondrial promoter | 1.062861e-3 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 1.082332e-3 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 1.142856e-3 |
GO:0016998 | cell wall macromolecule catabolic process | 1.154458e-3 |
GO:0048477 | oogenesis | 1.156553e-3 |
GO:0045578 | negative regulation of B cell differentiation | 1.210044e-3 |
GO:0071477 | cellular hypotonic salinity response | 1.222654e-3 |
GO:0035520 | monoubiquitinated protein deubiquitination | 1.222654e-3 |
GO:0051152 | positive regulation of smooth muscle cell differentiation | 1.265253e-3 |
GO:0032872 | regulation of stress-activated MAPK cascade | 1.302454e-3 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 1.344404e-3 |
GO:0001975 | response to amphetamine | 1.362107e-3 |
GO:0000303 | response to superoxide | 1.385744e-3 |
GO:0070535 | histone H2A K63-linked ubiquitination | 1.393215e-3 |
GO:0071624 | positive regulation of granulocyte chemotaxis | 1.393215e-3 |
GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA | 1.393215e-3 |
GO:0018872 | arsonoacetate metabolic process | 1.393215e-3 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 1.394074e-3 |
GO:0001835 | blastocyst hatching | 1.440256e-3 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 1.458580e-3 |
GO:0032119 | sequestering of zinc ion | 1.477790e-3 |
GO:0006399 | tRNA metabolic process | 1.548539e-3 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 1.554541e-3 |
GO:0045066 | regulatory T cell differentiation | 1.565478e-3 |
GO:0009152 | purine ribonucleotide biosynthetic process | 1.578725e-3 |
GO:0048535 | lymph node development | 1.622314e-3 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 1.629453e-3 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 1.629849e-3 |
GO:0042840 | D-glucuronate catabolic process | 1.633609e-3 |
GO:0019348 | dolichol metabolic process | 1.660213e-3 |
GO:0032965 | regulation of collagen biosynthetic process | 1.685757e-3 |
GO:0008063 | Toll signaling pathway | 1.764828e-3 |
GO:0006921 | cellular component disassembly involved in apoptosis | 1.783691e-3 |
GO:0032845 | negative regulation of homeostatic process | 1.804490e-3 |
GO:0045046 | protein import into peroxisome membrane | 1.806287e-3 |
GO:0006680 | glucosylceramide catabolic process | 1.806287e-3 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 1.825556e-3 |
GO:0061072 | iris morphogenesis | 1.855160e-3 |
GO:0042628 | mating plug formation | 1.855160e-3 |
GO:0016557 | peroxisome membrane biogenesis | 1.867074e-3 |
GO:0014842 | regulation of satellite cell proliferation | 1.867074e-3 |
GO:0035235 | ionotropic glutamate receptor signaling pathway | 1.891422e-3 |
GO:0006730 | one-carbon metabolic process | 1.894291e-3 |
GO:0060716 | labyrinthine layer blood vessel development | 1.905744e-3 |
GO:0032660 | regulation of interleukin-17 production | 1.956912e-3 |
GO:0009112 | nucleobase metabolic process | 1.976351e-3 |
GO:0006493 | protein O-linked glycosylation | 2.032216e-3 |
GO:0042420 | dopamine catabolic process | 2.215221e-3 |
GO:0048747 | muscle fiber development | 2.221297e-3 |
GO:0045605 | negative regulation of epidermal cell differentiation | 2.234851e-3 |
GO:0097039 | protein linear polyubiquitination | 2.277768e-3 |
GO:0071476 | cellular hypotonic response | 2.277768e-3 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.277768e-3 |
GO:0033629 | negative regulation of cell adhesion mediated by integrin | 2.277768e-3 |
GO:0051568 | histone H3-K4 methylation | 2.316459e-3 |
GO:0035522 | monoubiquitinated histone H2A deubiquitination | 2.346525e-3 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 2.346525e-3 |
GO:0032802 | low-density lipoprotein particle receptor catabolic process | 2.346525e-3 |
GO:0031100 | organ regeneration | 2.378255e-3 |
GO:0060674 | placenta blood vessel development | 2.389182e-3 |
GO:0060349 | bone morphogenesis | 2.404464e-3 |
GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 2.420682e-3 |
GO:0051135 | positive regulation of NK T cell activation | 2.449811e-3 |
GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis | 2.468069e-3 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 2.552103e-3 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 2.555444e-3 |
GO:0060363 | cranial suture morphogenesis | 2.561089e-3 |
GO:0051340 | regulation of ligase activity | 2.574737e-3 |
GO:0007320 | insemination | 2.600167e-3 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 2.621246e-3 |
GO:0001544 | initiation of primordial ovarian follicle growth | 2.751859e-3 |
GO:0043217 | myelin maintenance | 2.775254e-3 |
GO:2000271 | positive regulation of fibroblast apoptosis | 2.779348e-3 |
GO:2000270 | negative regulation of fibroblast apoptosis | 2.779348e-3 |
GO:0006097 | glyoxylate cycle | 2.779348e-3 |
GO:0044345 | stromal-epithelial cell signaling involved in prostate gland development | 2.779348e-3 |
GO:2000080 | negative regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 2.779348e-3 |
GO:0050691 | regulation of defense response to virus by host | 2.783401e-3 |
GO:0032388 | positive regulation of intracellular transport | 2.847777e-3 |
GO:0051238 | sequestering of metal ion | 2.850883e-3 |
GO:0060052 | neurofilament cytoskeleton organization | 2.916404e-3 |
GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 2.969519e-3 |
GO:0009103 | lipopolysaccharide biosynthetic process | 2.981384e-3 |
GO:0032647 | regulation of interferon-alpha production | 2.981384e-3 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 3.001306e-3 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 3.066957e-3 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 3.131779e-3 |
GO:0043687 | post-translational protein modification | 3.232952e-3 |
GO:0060084 | synaptic transmission involved in micturition | 3.273123e-3 |
GO:0042307 | positive regulation of protein import into nucleus | 3.409650e-3 |
GO:0006268 | DNA unwinding involved in replication | 3.450032e-3 |
GO:0016180 | snRNA processing | 3.453962e-3 |
GO:0009143 | nucleoside triphosphate catabolic process | 3.555916e-3 |
GO:0070244 | negative regulation of thymocyte apoptosis | 3.682315e-3 |
GO:0061136 | regulation of proteasomal protein catabolic process | 3.706105e-3 |
GO:0008334 | histone mRNA metabolic process | 3.716682e-3 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 3.724204e-3 |
GO:0021678 | third ventricle development | 3.735453e-3 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 3.737589e-3 |
GO:0021941 | negative regulation of cerebellar granule cell precursor proliferation | 3.737589e-3 |
GO:0048255 | mRNA stabilization | 3.897299e-3 |
GO:0007530 | sex determination | 3.897299e-3 |
GO:0048382 | mesendoderm development | 3.932235e-3 |
GO:0032700 | negative regulation of interleukin-17 production | 4.023408e-3 |
GO:0006429 | leucyl-tRNA aminoacylation | 4.082091e-3 |
GO:0071380 | cellular response to prostaglandin E stimulus | 4.186934e-3 |
GO:2000079 | regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 4.186934e-3 |
GO:0016139 | glycoside catabolic process | 4.186934e-3 |
GO:0002442 | serotonin secretion involved in inflammatory response | 4.186934e-3 |
GO:0002719 | negative regulation of cytokine production involved in immune response | 4.256714e-3 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 4.277769e-3 |
GO:0006270 | DNA-dependent DNA replication initiation | 4.292567e-3 |
GO:0043248 | proteasome assembly | 4.292567e-3 |
GO:0009109 | coenzyme catabolic process | 4.349426e-3 |
GO:0045359 | positive regulation of interferon-beta biosynthetic process | 4.392936e-3 |
GO:0010447 | response to acidity | 4.563807e-3 |
GO:0021549 | cerebellum development | 4.692716e-3 |
GO:0021784 | postganglionic parasympathetic nervous system development | 4.759329e-3 |
GO:0060029 | convergent extension involved in organogenesis | 4.860590e-3 |
GO:0030902 | hindbrain development | 4.862511e-3 |
GO:0017144 | drug metabolic process | 4.938199e-3 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 5.113561e-3 |
GO:0042273 | ribosomal large subunit biogenesis | 5.113561e-3 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 5.193104e-3 |
GO:0035195 | gene silencing by miRNA | 5.207982e-3 |
GO:0044253 | positive regulation of multicellular organismal metabolic process | 5.207982e-3 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 5.234266e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 5.283472e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 5.329005e-3 |
GO:0022904 | respiratory electron transport chain | 5.358799e-3 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 5.467585e-3 |
GO:0061054 | dermatome development | 5.467585e-3 |
GO:0034441 | plasma lipoprotein particle oxidation | 5.467585e-3 |
GO:0051188 | cofactor biosynthetic process | 5.497573e-3 |
GO:0009314 | response to radiation | 5.497939e-3 |
GO:0045454 | cell redox homeostasis | 5.509931e-3 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 5.577775e-3 |
GO:0031167 | rRNA methylation | 5.684503e-3 |
GO:0009088 | threonine biosynthetic process | 5.832163e-3 |
GO:0051610 | serotonin uptake | 5.832163e-3 |
GO:0003029 | detection of hypoxic conditions in blood by carotid body chemoreceptor signaling | 5.832163e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 5.832896e-3 |
GO:0002507 | tolerance induction | 5.930799e-3 |
GO:0022037 | metencephalon development | 5.944539e-3 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 6.080560e-3 |
GO:0044265 | cellular macromolecule catabolic process | 6.126242e-3 |
GO:0042744 | hydrogen peroxide catabolic process | 6.195232e-3 |
GO:0048352 | paraxial mesoderm structural organization | 6.346513e-3 |
GO:0021998 | neural plate mediolateral regionalization | 6.346513e-3 |
GO:0048743 | positive regulation of skeletal muscle fiber development | 6.375637e-3 |
GO:0007096 | regulation of exit from mitosis | 6.380127e-3 |
GO:0060009 | Sertoli cell development | 6.475237e-3 |
GO:0035194 | posttranscriptional gene silencing by RNA | 6.475710e-3 |
GO:0071481 | cellular response to X-ray | 6.664260e-3 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 6.694681e-3 |
GO:0006457 | protein folding | 6.758483e-3 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB cascade | 6.773742e-3 |
GO:0050935 | iridophore differentiation | 6.790604e-3 |
GO:0048937 | lateral line nerve glial cell development | 6.790604e-3 |
GO:0030168 | platelet activation | 6.841746e-3 |
GO:0048496 | maintenance of organ identity | 7.000394e-3 |
GO:0014816 | satellite cell differentiation | 7.000394e-3 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 7.000394e-3 |
GO:0048818 | positive regulation of hair follicle maturation | 7.012771e-3 |
GO:2000194 | regulation of female gonad development | 7.012771e-3 |
GO:0000281 | cytokinesis after mitosis | 7.012771e-3 |
GO:0001510 | RNA methylation | 7.063791e-3 |
GO:0034764 | positive regulation of transmembrane transport | 7.102478e-3 |
GO:0044240 | multicellular organismal lipid catabolic process | 7.112373e-3 |
GO:0002090 | regulation of receptor internalization | 7.254516e-3 |
GO:0006974 | response to DNA damage stimulus | 7.350425e-3 |
GO:0071472 | cellular response to salt stress | 7.420277e-3 |
GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 7.420277e-3 |
GO:0000729 | DNA double-strand break processing | 7.420277e-3 |
GO:0071300 | cellular response to retinoic acid | 7.432997e-3 |
GO:0051926 | negative regulation of calcium ion transport | 7.486368e-3 |
GO:0090316 | positive regulation of intracellular protein transport | 7.522420e-3 |
GO:0050428 | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process | 7.569055e-3 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 7.727093e-3 |
GO:0045104 | intermediate filament cytoskeleton organization | 7.767993e-3 |
GO:0032728 | positive regulation of interferon-beta production | 7.782766e-3 |
GO:0070922 | small RNA loading onto RISC | 7.803369e-3 |
GO:0006666 | 3-keto-sphinganine metabolic process | 7.803369e-3 |
GO:0046626 | regulation of insulin receptor signaling pathway | 7.813826e-3 |
GO:0043409 | negative regulation of MAPKKK cascade | 7.848820e-3 |
GO:0042401 | cellular biogenic amine biosynthetic process | 7.923407e-3 |
GO:0034629 | cellular protein complex localization | 7.970498e-3 |
GO:0018410 | C-terminal protein amino acid modification | 7.970498e-3 |
GO:0060152 | microtubule-based peroxisome localization | 8.218365e-3 |
GO:0045333 | cellular respiration | 8.234503e-3 |
GO:0009452 | RNA capping | 8.316932e-3 |
GO:2000655 | negative regulation of cellular response to testosterone stimulus | 8.450753e-3 |
GO:0051097 | negative regulation of helicase activity | 8.450753e-3 |
GO:0006343 | establishment of chromatin silencing | 8.450753e-3 |
GO:0031937 | positive regulation of chromatin silencing | 8.450753e-3 |
GO:0006422 | aspartyl-tRNA aminoacylation | 8.526922e-3 |
GO:0009108 | coenzyme biosynthetic process | 8.547793e-3 |
GO:0042424 | catecholamine catabolic process | 8.573308e-3 |
GO:0019673 | GDP-mannose metabolic process | 8.602808e-3 |
GO:0043046 | DNA methylation involved in gamete generation | 8.680564e-3 |
GO:0021548 | pons development | 8.803466e-3 |
GO:0051865 | protein autoubiquitination | 8.867214e-3 |
GO:0016090 | prenol metabolic process | 8.928104e-3 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 9.059321e-3 |
GO:0008088 | axon cargo transport | 9.140258e-3 |
GO:0009154 | purine ribonucleotide catabolic process | 9.278641e-3 |
GO:0007549 | dosage compensation | 9.299349e-3 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 9.355007e-3 |
GO:0046940 | nucleoside monophosphate phosphorylation | 9.400970e-3 |
GO:0034421 | post-translational protein acetylation | 9.400970e-3 |
GO:0030421 | defecation | 9.400970e-3 |
GO:0007099 | centriole replication | 9.471363e-3 |
GO:0000959 | mitochondrial RNA metabolic process | 9.471363e-3 |
GO:0060339 | negative regulation of type I interferon-mediated signaling pathway | 9.530570e-3 |
GO:0033566 | gamma-tubulin complex localization | 9.530570e-3 |
GO:0001834 | trophectodermal cell proliferation | 9.530570e-3 |
GO:0032481 | positive regulation of type I interferon production | 9.550867e-3 |
GO:0009141 | nucleoside triphosphate metabolic process | 9.557326e-3 |
GO:0002293 | alpha-beta T cell differentiation involved in immune response | 9.588936e-3 |
GO:0071299 | cellular response to vitamin A | 9.730058e-3 |
GO:0030210 | heparin biosynthetic process | 9.854364e-3 |
GO:0030432 | peristalsis | 9.930002e-3 |
GO:0061056 | sclerotome development | 9.971355e-3 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 1.006701e-2 |
GO:0002701 | negative regulation of production of molecular mediator of immune response | 1.015477e-2 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.023344e-2 |
GO:0002763 | positive regulation of myeloid leukocyte differentiation | 1.025743e-2 |
GO:0046112 | nucleobase biosynthetic process | 1.032725e-2 |
GO:0009261 | ribonucleotide catabolic process | 1.037160e-2 |
GO:0006047 | UDP-N-acetylglucosamine metabolic process | 1.039172e-2 |
GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 1.040698e-2 |
GO:0048630 | skeletal muscle tissue growth | 1.046926e-2 |
GO:0032933 | SREBP-mediated signaling pathway | 1.056517e-2 |
GO:0006184 | GTP catabolic process | 1.059463e-2 |
GO:0046477 | glycosylceramide catabolic process | 1.068047e-2 |
GO:2000195 | negative regulation of female gonad development | 1.068047e-2 |
GO:0018130 | heterocycle biosynthetic process | 1.115318e-2 |
GO:0060055 | angiogenesis involved in wound healing | 1.116993e-2 |
GO:0018195 | peptidyl-arginine modification | 1.116993e-2 |
GO:0051764 | actin crosslink formation | 1.118553e-2 |
GO:0043488 | regulation of mRNA stability | 1.139082e-2 |
GO:2000018 | regulation of male gonad development | 1.156241e-2 |
GO:0072539 | T-helper 17 cell differentiation | 1.163657e-2 |
GO:0021536 | diencephalon development | 1.181117e-2 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 1.211193e-2 |
GO:0006612 | protein targeting to membrane | 1.211896e-2 |
GO:0007049 | cell cycle | 1.223919e-2 |
GO:0048880 | sensory system development | 1.249420e-2 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 1.249420e-2 |
GO:0035608 | protein deglutamylation | 1.249420e-2 |
GO:0002224 | toll-like receptor signaling pathway | 1.253100e-2 |
GO:0035065 | regulation of histone acetylation | 1.256788e-2 |
GO:0030719 | P granule organization | 1.283420e-2 |